BOT 1.43% 34.5¢ botanix pharmaceuticals ltd

Ann: Botanix Webinar - Presentation Copy, page-196

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 6,609 Posts.
    lightbulb Created with Sketch. 476
    I left it in USA dollars just to be more conservative lol
    Bottom line is plenty of revenue will roll in

    As well this is a very sticky product
    Customer retention will be high for a long time
    For example customers with heart burn don’t just use for instance nexium for a year they will use it for ever unless there is an alternative use
    Same thing here
    So expecting repeat customers year on year
    Don’t think this has been discussed by the board much
    They did mention yesterday’s webinar people have it for life or till 60? so you will think say a 20 year old with hypohidrosis won’t just use 3 refills ? And stop being a customer just like that
    Recurring revenue starts kicking hard as the company matures
 
watchlist Created with Sketch. Add BOT (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.